AMIKACIN SULFATE INJECTION USP
SANDOZ CANADA INCORPORATED
Quick answers
Is there a shortage of AMIKACIN SULFATE INJECTION USP in Canada?
No. There is no current shortage of AMIKACIN SULFATE INJECTION USP 250MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
AMIKIN
BRISTOL-MYERS SQUIBB CANADA
AMIKACIN SULFATE INJECTION
JUNO PHARMACEUTICALS CORP.
AMIKACIN SULFATE INJECTION USP
MARCAN PHARMACEUTICALS INC
VPI-AMIKACIN
VPI PHARMACEUTICALS INC
DIN
02242971
Strength
250MG
Dosage Form
Liquid
Route
Intramuscular Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
50MG · DIN 02242325
DIN 02495910
DIN 02495929
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759
5MG · DIN 02299925